{"disease":{"id":"mixed-dyslipidemia","name":"mixed dyslipidemia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07409636","title":"A Study to Assess the Real-World Effectiveness of Inclisiran and PCSK9 mAbs in Chinese Hypercholesterolemia Adult Patients","phase":"","overall_status":"COMPLETED","enrollment_count":11991,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT04579367","title":"Treatment With Bempedoic Acid and/or Its Fixed-dose Combination With Ezetimibe in Primary Hypercholesterolemia or Mixed Dyslipidemia","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":5000,"lead_sponsor_name":"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company","has_results":false},{"nct_id":"NCT06204380","title":"An Observational Study on the Identification of Prescription Patterns of STAFEN Cap","phase":"","overall_status":"UNKNOWN","enrollment_count":4000,"lead_sponsor_name":"Hanlim Pharm. Co., Ltd.","has_results":false},{"nct_id":"NCT01854918","title":"Open-label Extension Study of Evolocumab (AMG 145) in Adults With Hyperlipidemia and Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":3681,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT07206472","title":"A Study of Bempedoic Acid or Its Single-pill Combination Therapy With Ezetimibe in Patients With Primary Hypercholesterolaemia or Mixed Dyslipidaemia","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":2560,"lead_sponsor_name":"Daiichi Sankyo","has_results":false},{"nct_id":"NCT00479882","title":"MK-0524B Lipid Study (MK-0524B-063)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":2414,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06686615","title":"A Study of Bempedoic Acid in Combination With Ezetimibe and Either Rosuvastatin or Atorvastatin in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia","phase":"","overall_status":"RECRUITING","enrollment_count":2000,"lead_sponsor_name":"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company","has_results":false},{"nct_id":"NCT06770543","title":"Leqvio rPMS (Regulatory Post-Marketing Surveillance in Korea)","phase":"","overall_status":"RECRUITING","enrollment_count":1500,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT01274559","title":"Efficacy and Safety of Extended Release (ER) Niacin/Laropiprant When Added to Ongoing Lipid-Modifying Therapy in Patients With High Cholesterol or Abnormal Lipid Levels (MK-0524A-133)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1173,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT01335997","title":"Efficacy and Safety of Extended-Release Niacin/ Laropiprant/Simvastatin Tablets in Participants With Hypercholesterolemia or Mixed Dyslipidemia (MK-0524B-143)","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":1139,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT02662569","title":"Safety and Efficacy of Evolocumab in Combination With Statin Therapy in Adults With Diabetes and Hyperlipidemia or Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":986,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05399992","title":"Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":847,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT07253584","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled Phase III Clinical Study to Evaluate the Safety and Efficacy of SAL003 in Combination With Statin Therapy in Patients With Hypercholesterolemia and Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":720,"lead_sponsor_name":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT05621070","title":"Efficacy and Safety of JS002 as Monotherapy in Patients With Primary Hypercholesterolaemia and Mixed Dyslipidemia","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":582,"lead_sponsor_name":"Shanghai Junshi Bioscience Co., Ltd.","has_results":false},{"nct_id":"NCT05400317","title":"A Study to Evaluate the Efficacy and Safety of AD-218","phase":"PHASE3","overall_status":"RECRUITING","enrollment_count":520,"lead_sponsor_name":"Addpharma Inc.","has_results":false},{"nct_id":"NCT05546398","title":"SurveY Followed by a Retrospective Chart Review to Describe the Key Factors Leading to Physician's Decision to Treat Patients at High and Very High Cardiovascular Risk With hyperchOlesterolemia or Mixed Dyslipidemia With NUSTENDI®","phase":"","overall_status":"COMPLETED","enrollment_count":500,"lead_sponsor_name":"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company","has_results":false},{"nct_id":"NCT02739984","title":"Evaluation of Evolocumab (AMG 145) Efficacy in Diabetic Adults With Hypercholesterolemia/Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":424,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT04643093","title":"Compare the Efficacy and Safety of 1PC111 With Pitavastatin and Ezetimibe in Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":390,"lead_sponsor_name":"Orient Pharma Co., Ltd.","has_results":false},{"nct_id":"NCT04998201","title":"Study of Plozasiran (ARO-APOC3) in Adults With Mixed Dyslipidemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":353,"lead_sponsor_name":"Arrowhead Pharmaceuticals","has_results":true},{"nct_id":"NCT03433755","title":"Safety and Efficacy of Evolocumab in Addition to Optimal Stable Background Statin Therapy in Chinese Participants With Primary Hypercholesterolemia and Mixed Dyslipidemia","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":259,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT07278830","title":"A Phase II Study to Evaluate the Safety and Efficacy of SAL003 Combined With Atorvastatin in Hypercholesterolemia and Mixed Dyslipidemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":214,"lead_sponsor_name":"Shenzhen Salubris Pharmaceuticals Co., Ltd.","has_results":false},{"nct_id":"NCT05888103","title":"Efficacy and Safety of Inclisiran as Monotherapy in Chinese Adults With Low or Moderate ASCVD Risk and Elevated Low-density Lipoprotein Cholesterol.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":207,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":true},{"nct_id":"NCT04832971","title":"Study of ARO-ANG3 in Adults With Mixed Dyslipidemia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":204,"lead_sponsor_name":"Arrowhead Pharmaceuticals","has_results":true},{"nct_id":"NCT07444762","title":"Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of DW5421A","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":184,"lead_sponsor_name":"Daewon Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT01879319","title":"Study to Assess in Home Use of Evolocumab (AMG 145) Administration Using Either an Automated Mini-doser or a Prefilled Autoinjector/Pen","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT01849497","title":"Study to Assess In-home Use of Evolocumab (AMG 145) Using a Prefilled Syringe or a Prefilled Autoinjector/Pen","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":149,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT06497127","title":"A Study in Patients With Mixed Dyslipidemia","phase":"PHASE2","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":145,"lead_sponsor_name":"Shanghai Argo Biopharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT07474649","title":"A Study of Bempedoic Acid/Ezetimibe/High-intensity Statin in Patients Without Cardiovascular Events","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":103,"lead_sponsor_name":"Daiichi Sankyo","has_results":false},{"nct_id":"NCT02189837","title":"Effects on Lipoprotein Metabolism From PCSK9 Inhibition Utilizing a Monoclonal Antibody","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":89,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05118230","title":"Study to Assess the Real World Effectiveness of Inclisiran in Chinese Adult Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia","phase":"","overall_status":"COMPLETED","enrollment_count":61,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT07319559","title":"Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on DW5124 in Healthy Adult Volunteers","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Daewon Pharmaceutical Co., Ltd.","has_results":false},{"nct_id":"NCT06386419","title":"A Clinical Study to Evaluate the Safety and Effectiveness of Inclisiran Sodium in Indian Patients With Primary Hypercholesterolemia or Mixed Dyslipidemia","phase":"PHASE4","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":32,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT02275156","title":"Estimation Study to Assess the Effect of Severe Renal Impairment and End-stage Renal Disease Hemodialysis on the Pharmacokinetics of Evolocumab","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":18,"lead_sponsor_name":"Amgen","has_results":true},{"nct_id":"NCT05798390","title":"Treatment With Bempedoic Acid And/Or Its Fixed-dose Combination With Ezetimibe in Routine Clinical Practice in Patients With Primary Hypercholesterolemia Or Mixed Dyslipidemia","phase":"","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company","has_results":false},{"nct_id":"NCT02947334","title":"Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Pfizer","has_results":false}],"total":35},"guidelines":[],"source":"Drug Landscape verified database"}